COCP
Closed
Cocrystal Pharma Inc
1.49
0.00 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.49
Day's Range: 1.45 - 1.52
Send
sign up or login to leave a comment!
When Written:
1.99
Cocrystal Pharma Inc. is a biotechnology company that focuses on the discovery and development of antiviral therapeutics for the treatment of serious and/or chronic viral diseases. The company uses a proprietary platform technology to identify novel drug candidates that target viral replication and infectivity.
Cocrystal Pharma's lead drug candidate is CC-31244, which is being developed for the treatment of hepatitis C virus (HCV) infection. The company is also developing other antiviral programs for the treatment of influenza, norovirus, and coronavirus infections.
Cocrystal Pharma was founded in 2013 and is headquartered in Bothell, Washington. The company is publicly traded on the NASDAQ under the ticker symbol COCP.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Cocrystal Pharma's lead drug candidate is CC-31244, which is being developed for the treatment of hepatitis C virus (HCV) infection. The company is also developing other antiviral programs for the treatment of influenza, norovirus, and coronavirus infections.
Cocrystal Pharma was founded in 2013 and is headquartered in Bothell, Washington. The company is publicly traded on the NASDAQ under the ticker symbol COCP.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








